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A National Biomedical Risk Factor Survey for Australia: 
 
Issues for consideration 
 
 
National population health surveys containing a component of physical 
measurement have been used both in Australia and overseas to add to the 
information about the state of health of a population and to complement 
research into particular issues, diseases or directions in health policy. 
 
Such a survey has been proposed recently for Australia, with initial planning and 
costing undertaken by the Australian Institute for Health and Welfare (AIHW) over 
the last two years.  However, given the Institute’s identified need for an 
investment of at least $3 million, additional planning and development has been 
agreed by the Commonwealth Department of Health and Aged Care and AIHW 
for the scope of a survey, the cost and the likely value of its results.  The National 
Public Health Partnership has endorsed this approach. 
 
This short paper will outline some of the issues that require consideration as part 
of the decision-making about these types of surveys in general, and will report 
briefly on some of the models that have been used overseas. 
 
 
1.0 The primary reasons for undertaking biomedical risk factor surveys 
 
From an examination of the use of surveys of this type that have been 
undertaken in the United States, Canada, New Zealand, the United Kingdom and 
Australia, the following purposes have been identified.  Biomedical risk factor 
surveys have been used for: 
 The monitoring within a population of certain high priority health goals and 
targets relating to the prevention of various diseases or conditions at one 
point in time, and over time if surveys are repeated regularly; 
 The provision of baseline data related to particular health issues or policies; 
 The contribution to particular research questions about health and related 
conditions and their treatment or eradication; 
 The surveillance of infective agents or other factors that impact negatively on 
the population’s health or may do so in the future; 
 The collection of information at a population level - to assist in the 
development of policy and planning of services or determining need, to 
assess the degree of success of health promotion or illness prevention 
strategies or to contribute to a greater understanding of health and illness.   
 
The primary purpose of the proposed AIHW survey was to monitor disease risk 
patterns, by collecting national information on risk factors and their distribution, 
assessing trends in risk factors by comparing results with previous survey data 
and validating self-reported health conditions, health status and behaviours. 
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One issue requiring clarification is whether the purpose of a biomedical risk 
factor survey for Australia is primarily to monitor the health of the population, or 
if it will also contribute to an understanding about the population’s health and 
well being and its genetic, biologic and social determinants.  Such decisions will 
impact significantly on the areas to be covered by the survey - the nature of the 
questions and any biologic markers or measures to be included, components of 
survey design and sampling, any sub-populations of interest, extent of consent 
required and other significant legal and ethical issues, consumer response rates, 
extent of funding, organisational infrastructure needed to support a survey and 
subsequent issues of survey design, data and sample storage, record linkage and 
trend analysis. 
 
It will be important to consider carefully, which of these purposes, monitoring 
alone or with the ability to contribute to the knowledge base as well, is the 
impetus for a national survey of this kind.  It will also determine the perceived 
value of any survey for those who have the responsibility for deciding whether 
such a survey should proceed. 
 
 
2.0 A national biomedical risk factor survey and its place in the longer 
term direction of national population health information development 
 
There has been a considerable investment by governments and others in the 
collection of health information and concomitant biomedical and other measures 
to date in Australia, although one of those studies is now ten years old.  The 
International Diabetes Institute (IDI) has received significant funding recently for a 
major study into the prevalence of diabetes and cardiovascular disease 
(AUSDIAB) and associated risk factors, which is currently underway.  A number 
of physical measures that were included in the AIHW survey proposal are being 
gathered as part of the AUSDIAB survey. 
 
The National Public Health Information Development Plan has been published 
and its stated purpose is ‘to identify the action needed to improve public health 
information in Australia’.  A biomedical risk factor survey is included as one of its 
components (Recommendation 1.1.1).  However, it is not clear how widely this 
particular direction has been canvassed with a range of other interested parties, 
beyond the NPHP and NPHIWG. 
 
There are a number of broader questions to be considered.  
What are the longer-term policy questions or issues that should form the basis of 
a national population health survey that includes physical measures? 
What health issues are important to consider now, and which are likely to emerge 
as significant for our nation over the next ten or twenty years?  
What are the significant gaps in information currently that a survey of this kind 
could help to remedy?  
Are there certain population groups that should be considered as a priority for 
inclusion? 
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What are the directions for future population health surveying and collection 
nationally, and how does a national biomedical risk factor survey program fit 
within a longer-term view?   
 
It is also not yet apparent how priorities for population health, which would be 
included in a survey of this kind, might be determined across the Department of 
Health and Aged Care and in partnership with other jurisdictions.  For example, 
to what extent are State and Territory health agencies interested in participating 
in the survey direction, design and funding?  Will they be supportive of national 
directions solely, or will they wish to raise local issues for inclusion and to fund 
possible State estimates?  What are the interests of other public health 
practitioners, community and professional organisations, and researchers from 
tertiary educational institutions?  Are other divisions within the Commonwealth 
Department of Health and Aged Care interested in and supportive of a survey?  
Are there areas that overlap with the interests of other sectors?  Are there 
emerging health issues that ought to be considered for inclusion?   
 
An agreement to the investment of a significant amount of health funding in a 
national biomedical risk factor survey requires support from a range of parties 
who have an interest in health policy issues.  There is an urgent need to 
undertake discussions with the State and Territory health authorities and a range 
of other stakeholders.  This is necessary in order to determine the level of interest 
in a survey, the perception of its value and importance, views on priority issues 
for inclusion (and the criteria for deciding which issues will be included), funding 
options and the preferred process for its development, should it proceed. 
 
A wide level of commitment to the undertaking of a survey and its objectives will 
be essential before the issue can proceed successfully through AHMAC 
processes and beyond.  Furthermore, all stakeholders will need to be committed 
fully in order to be able to respond positively to the likely community interest that 
will be generated once the survey is agreed and publicised. 
 
 
3.0 The content of a national biomedical risk factor survey 
 
The planning work undertaken by the AIHW resulted in a focus on issues that are 
generally recognised as contributing to significant mortality and morbidity within 
the Australian adult population.  Its recommendations for topics for inclusion are 
cardiovascular disease, diabetes mellitus, communicable diseases and nutrition.   
 
The report of the workshop (AIHW March 1998) indicated that the participants 
gave priority to the areas above and, after discussion, excluded genetics and 
cancer from the survey.  Participants identified a range of biologic markers for 
inclusion, and canvassed the possibilities of including children and young people 
as subjects, using collected sera for further research, linking results with data 
held by AIHW and the Australian Bureau of Statistics (ABS) and conducting the 
survey in rural and remote communities or for high-risk sub-populations.   
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Over two years have now passed since the initial AIHW workshop and there have 
been a number of new areas of interest identified.  To date, there has not been a 
broad scoping exercise regarding the content and design of a national survey.  
Those with expertise in areas such as child and youth health, Indigenous health, 
disability or the health of recent immigrant populations, for example, have not yet 
been consulted.  Other significant health issues such as substance use, injury 
and violence, oral health, respiratory disease and the emerging interest in 
autonomy and control and other psychosocial contributors to health and illness 
might be considered for possible inclusion.   
 
Further discussion is now needed about the areas for inclusion if such a survey 
were to be conducted.  There are other health issues, such as nutritional deficits 
in Indigenous people, environmental health effects of various contaminants, risk 
factors for mental health, childhood antecedents of adult disease and other 
population health determinants that could be considered.  An examination of the 
biologic markers that have already been collected in overseas surveys suggests 
that there may be value in including markers such as fibrinogen, homocysteine 
and others, and in considering some physical measures of respiratory status and 
other fitness indicators. Furthermore, there are convincing arguments for 
considering the inclusion of children and young people in surveys such as these. 
 
Communication with Canadian authorities who are currently planning their own 
national biomedical risk factor survey, indicates that a substantial amount of 
planning and research is needed, in order to ensure that the significant 
investment of money required for surveys of this kind is realised in valuable and 
useful results which lead to better health strategies for the population, and that 




4.0 Other sources of population health information to determine risk 
factor prevalence 
 
There are a number of current initiatives that should be examined to determine 
whether they could contribute to the collection of information that is to be 
covered by a national survey of risk factor prevalence.   
 
Such approaches include a possible expansion of the BEACH survey, linkage to 
the IDI Diabetes Prevalence Survey (AUSDIAB), the use of CATI methodology for 
surveying and its link to clinic services for sampling and physical examinations, 
and the options of funding studies using surveying and blood samples which are 
already collected in significant numbers elsewhere (for example, through blood 
donation or via private pathology laboratories).  These options may prove not to 
be suitable after detailed examination, but nevertheless, deserve consideration at 
this stage.  There are also a number of regional surveys underway or seeking 
funding from sources such as the NHMRC that may be worth considering as 
elements in building a picture of risk factor prevalence.  Data management 
issues will also need to be considered in detail. 
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5.0 Legal and ethical considerations for consumer involvement 
 
There are a large number of legal and ethical issues that emerge once a survey 
with biologic blood and other physical markers is proposed.  These need careful 
attention and discussion, and some may require legal opinions to reduce the 
likelihood of future legal claims and liability. 
 
Consumer involvement in a survey of this kind will be critical in determining its 
success, given the response rates that are needed to ensure that sampling is 
representative of the population(s) of interest.  Significant investment will be 
required to encourage consumer participation and support at every stage of the 
survey.  Initial discussions with colleagues in New Zealand indicate that their 
most effective strategy to encourage participation in The NZ National Nutrition 
Survey involved local community newspaper stories about the survey, with a local 
interviewer being photographed.  The interviewer then took the newspaper article 
with them to remind participants of the survey, and the interviewers found it very 
effective.  Marketing to the community also took many other forms, and a part 
time communications person was employed to organise television and radio 
interviews, local newspaper stories and photographic opportunities.  
 
Consumer confidentiality and privacy concerns will require a concerted effort and 
a planned strategy to allay fears of data collection, storage, security and access 
to researchers for analyses.  Consumer anxieties are also likely to be heightened 
when biomedical sampling, particularly of blood, is initially raised in the public 
domain.  The benefits of the survey and aspects of the methodology will need to 
be asserted and discussed fully. 
 
Issues of the extent of the consent to be sought from participants will be largely 
determined by the nature of the survey, its content and the age groups who will 
be asked to participate.  All the usual provisions regarding informed consent will 
be required and explicit information about every aspect of the survey should be 
clearly outlined.  Languages other than English and the use of interpreters, 
literacy levels, and the ability to understand and to give one’s own consent will 
need to be thought through carefully.  Cultural considerations will also be 
important. 
 
A number of issues regarding information for participants are immediately 
apparent.  All participants should be given the opportunity to receive results from 
the survey, but this will not be straightforward.  For example, if a testing 
procedure reveals a result that indicates that the person’s sample is abnormal or 
indeterminate, what level of reliability and sensitivity does this represent?  What 
does an abnormal result mean for the person’s physical and mental well being, 
and future health?  Who will be responsible for talking to the person and 
explaining the results?  To whom should the information be given – the subject 
or his/her general practitioner, or both?  What about people who do not have a 
general practitioner?  What about the case of a young person under the age of 
18 years and what is the duty of care to a young person whose legal guardians 
refuse to disclose an abnormal result?  What about the psychological impact of 
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transmitting a false positive result to a person and subsequently discovering that 
it has been made in error?  What about the need to notify certain conditions to 
State or Territory public health authorities, and the inability then to maintain a 
person’s confidentiality?   
 
Specific problems are related to aspects of the final survey design.  For example, 
if sera are to be stored for future research or surveillance purposes, will they be 
identifiable?  For how long will samples be stored and how securely will they be 
stored?  Will they be available for DNA testing or research into genetic markers or 
diseases?  What about pre- and post-test counselling if viral or genetic markers 
are tested?  Who will do this?  Will permission for linkage to administrative or 
clinical databases be sought?  Will there be any attempts to incorporate 
longitudinal cohorts within the sample range?  Many other issues such as these 
will require elucidation, discussion and possible ethical approval. 
 
Many of these issues will require consideration under various State, Territory and 
Commonwealth legislation, and some will require specific ethical approvals.  
Consumer consultation and involvement will be a critical element of planning a 
survey of this kind. 
 
 
6.0 Logistical issues for biomedical sampling and physical measures 
 
The desire to sample blood and possibly other physiological substances such as 
saliva and urine as part of a national survey brings with it a significant number of 
complex issues that will require discussion and resolution, and will influence the 
cost of the survey significantly.  Some of these that relate to blood sampling are 
outlined in Attachment 1. 
 
Standardisation of sample collection and of physical measures will be required as 
well as a detailed discussion of the processes to be used.  A range of standard 
protocols exist for sample collection and the measurement of factors such as 
blood pressure, but these will need to be examined in detail and expert advice 
sought as to the level of standardisation that should be employed. 
 
It will be more difficult to decide on the process of whom should take the 
samples and perform the measurements, and when and where the samples are 
taken (eg. in the home, at a clinic, at a mobile testing centre).  Options include: 
 training one specially recruited team of collectors employed by the surveying 
body which travels from site to site; 
 using regional teams of people who receive training and service their local 
area; 
 contracting collection to organisations who have staff already employed and 
trained for venesection, and have accredited processes for blood collection, 
transport and testing, eg. private pathology services, blood transfusion 
services. 
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All collectors will require training to some degree, strict supervision and 
adherence to protocols, and monitoring to ensure to quality assurance and inter-
collector reliability throughout the survey. 
 
 
7.0 Issues of linkage to a National Health Survey (ABS) 
 
To date, the development of a national biomedical risk factor survey has been 
driven by the desire to link such a survey with a National Health Survey (NHS) run 
by the ABS.  There are a number of advantages to linking the two surveys.  
Response rates for ABS Health Surveys have been high, at about 90% or so, and 
linkage will result in the gathering of a raft of demographic, socioeconomic and 
health data in a way that has not previously been attempted on this scale.  This 
will allow a broad picture of the population’s health to be achieved.   
 
However there are a number of factors to be considered.  To date, the ABS has 
not undertaken a survey of this kind, involving a wide range of blood samples 
and physical measures.  Given the complexities of such a process and a relative 
lack of familiarity with these aspects of data collection, there will need to be a 
detailed process negotiated if this option is followed.   
 
There is interest in chronic disease risk factor surveillance following work on an 
integrated framework for chronic disease prevention by DHAC.  A need for a 
chronic disease risk factor surveillance system has been identified to support this 
work, possibly incorporating both biomedical and behavioural risk factor 
surveillance.  By 2004, it will be timely to repeat the National Nutrition Survey, so 
there is a possibility of uncoupling a biomedical risk factor survey from the ABS 
NHS and attaching it to a National Nutrition Survey.  This would give a 
biomedical survey the detailed nutrition questions that are lacking from the NHS 
(there are only six questions about nutrition in the NHS). 
 
Linkage with the National Health Survey will also not be easy from a practical 
perspective.  The Survey is a continuous, multi-stage population survey over 
twelve months, collecting an extensive range of data (which will contribute to the 
background information required for a biomedical risk factor survey).  How many 
collection points will be required?  What time delay between interview, and the 
taking of physical and blood measures will be acceptable?  Will collections for 
rural and remote populations be attempted?  Will the ABS employ the collectors 
of the biomedical and other measures, or will another organisation do so? 
 
It may be that the ABS National Health Survey is not the best vehicle to which to 
link a survey of this kind.  There may be alternative ways of proceeding that 
would offer a more practical approach given the logistical difficulties outlined 
above.  Are there other strategies that would be operationally more efficient, such 
as the collection of all information by a team (including a nurse) or the use of 
CATI procedures to establish convenient appointments for respondents to attend 
local ‘clinics’ for examination?  Are there additional opportunities for self-
administered mail back questionnaires or are there other research areas that 
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utilise attitudinal measurement scales?  In addition, sampling size and other 
sampling issues should not necessarily be pre-determined by the requirements of 
the ABS NHS for the survey.  Sample size, for example, should be determined by 
the nature of the outcomes that are sought. 
 
It may be important to consider selecting an agency or agencies, or a team of 
people with proven experience in all aspects of a survey such as this, from data 
collection, processing, analysis and publication.  Opportunities for contracting 
aspects of the survey administration should be considered. 
 
A final issue for consideration is that of data analysis and research opportunities 
once the survey has been conducted.  There are stringent legislative provisions 
that guide the ABS and its release of data.  This may restrict access to 
confidential data for record linkage, for a longitudinal sub-sample or for further 
research interests into stored sera for example.  There is also a precedent for 
information to be made available only at extra cost, in addition to that paid 
initially for the data to be collected.  However, there is a recent agreement 
between the ABS and the Australian universities regarding access to NHS data at 
no extra cost.  Experience overseas suggests that health survey bodies make data 
available widely and at reduced or no cost.  
 
Significant effort will need to be invested in the analysis of the data once it has 
been collected, in order for the financial investment to be realised.  There may be 
opportunities for researchers with a wide range of interests to assist in the 
analysis, if they are allowed access to the data.  This should lead to a quicker 
output of information from the survey and improved dissemination of the 
findings.  There may also be opportunities to undertake record linkage with other 
administrative collections if consent and privacy issues are dealt with, and there 
may be ways of commencing a population based longitudinal cohort within the 
survey as well. 
 
 
8.0 Biomedical risk factor survey experience overseas 
 
8.1 United States of America (USA) 
 
The USA has an extensive and sophisticated program of surveys and data 
collection systems under the auspice of the National Center for Health Statistics 
(NCHS), which is part of the Centers for Disease Control and Prevention.  Some 
NCHS data systems and surveys are ongoing annual systems while others are 
conducted periodically.   NCHS has two major types of data systems: systems 
based on populations, containing data collected through personal interviews or 
examinations; and systems based on records, containing data collected from 
vital and medical records.   
 
They include: 
National Health Interview Survey 
                  National Health Interview Survey on Disability 
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                  State & Local Area Integrated Telephone Survey (CATI-equivalent) 
            National Immunization Survey 
            National Health and Nutrition Examination Survey (NHANES) 
                  NHANES I Epidemiologic Followup Study  
            National Survey of Family Growth 
            National Health Care Survey 
                  Ambulatory Health Care Data (NAMCS/NHAMCS) 
                  Hospital Discharge and Ambulatory Surgery Data 
                  National Home and Hospice Care Survey 
                  National Nursing Home Survey 
             National Employer Health Insurance Survey 
             National Mortality Followback Survey 
             National Maternal and Infant Health Survey 
             National Vital Statistics System 
                  Birth Data  
                  Mortality Data  
                  Fetal Death Data 
                  Linked Births/Infant Deaths 
 
Since 1960, the National Center for Health Statistics (NCHS) has been 
responsible for producing vital and health statistics for the United States.  NCHS 
has legislative authority under the Public Health Service Act to collect statistics 
on the extent and nature of illness and disability of the population; 
environmental, social, and other health hazards; determinants of health; health 
resources; and utilization of health care.  The National Nutrition Monitoring and 
Related Research Act of 1990 directs the Departments of Health and Human 
Services and Agriculture to strengthen national nutrition monitoring and to 
implement a plan to assess the dietary and nutritional status of the U.S. 
population on a continuous basis.  The National Health and Nutrition 
Examination Survey (NHANES) is the cornerstone of the National Nutrition 
Monitoring and Related Research Program, providing data needed for nutrition 
monitoring, food fortification policy, establishing dietary guidelines, and 
assessing government programs and initiatives such as the Healthy People 2000 
and 2010 objectives of the Department of Health and Human Services. 
 
The goals of NHANES follow: 
 to estimate the number and percent of persons in the U.S. population and 
designated subgroups with selected diseases and risk factors; 
 to monitor trends in the prevalence, awareness, treatment, and control of 
selected diseases; 
 to monitor trends in risk behaviors and environmental exposures; 
 to analyse risk factors for selected diseases; 
 to study the relationship between diet, nutrition, and health; 
 to explore emerging public health issues and new technologies; and 




The NHANES has been a program of periodic surveys conducted by NCHS.  
Examination surveys undertaken since 1960 have provided national estimates of 
health and nutritional status of the US civilian non-institutionalised population, 
using nationally representative samples.  NHANES has taken a new direction 
beginning in 1998.  The major differences from previous Health and Nutrition 
Examination Surveys are that NHANES is now being implemented as a 
continuous, annual survey, and that it will be linked to related Federal 
Government data collections conducted on the general United States (US) 
population, in particular, the National Health Interview Survey (NHIS) and, 
potentially, the US Department of Agriculture's food consumption surveys.  The 
Program also has permanent ongoing funding under federal legislation enacted 
in 1992. 
 
Previously, researchers needed to use the entire 4 or 6-year sample in order to 
make even the broadest statistical estimates, because data were only 
representative of the entire population if one used the entire sample period. 
Researchers sometimes had to wait as long as 10 years after data collection 
before gaining access to data based on the entire 6-year sample. From 1998, 
NHANES has collected data from a representative sample of the U.S. population, 
newborns and older, every year. The new design has also allowed increased 
flexibility in survey content.  
 
NHANES is linked to NHIS at the Primary Sampling Unit (PSU) level (i.e., the 
same counties, but not necessarily the same individuals, will be in both surveys).  
NHANES will also be linked to NHIS with regard to questionnaire content of the 
household interview, for selected topics.  Links to Medicare and National Death 
Index records permit longitudinal/historical studies of disease. 
 
These interrelationships with existing surveys and databases follow the 
Department of Health and Human Services' Survey Integration Plan.  In addition, 
USDA's Continuing Survey of Food Intakes by Individuals (CSFII) will be merged 
with NHANES in year 2000.  Work is underway to conduct additional research 
and development of a computer-assisted dietary interview method by USDA in 
collaboration with NCHS.   
 
The NHANES I Epidemiologic Followup Study (NHEFS) is a national longitudinal 
study designed to investigate the relationships between clinical, nutritional, and 
behavioral factors assessed at baseline NHANES I, and subsequent morbidity, 
mortality, and institutionalization.  The NHEFS population includes the 14,407 
participants who were 25-74 years of age when first examined in NHANES I 
(1971-75).  NHEFS is a collaborative project involving NCHS, the National 
Institute of Aging, other components of the National Institute of Health, the 
Substance Abuse and Mental Health Services Administration, and other Centers 
in the Centers for Disease Control and Prevention.  NHEFS provides data on 
mortality, morbidity, and hospital utilization as well as changes in risk factors, 




The first wave (1982-84) of data collection was conducted for all members of the 
NHEFS cohort.  It included tracing the cohort; conducting personal interviews 
with subjects or their proxies; measuring pulse rate, weight, and blood pressure 
of surviving participants; collecting hospital and nursing home records of 
overnight stays; and collecting death certificates of decedents. 
Continued follow ups of the NHEFS population were conducted in 1986, 1987, 
and 1992 using the same design and data collection procedures developed in 
the 1982-84 NHEFS, with the exception that a 30-minute computer-assisted 
telephone interview was administered rather than a personal interview, and no 
physical measurements were taken.  The 1986 NHEFS was conducted on 
members of the cohort who were 55-74 years of age at their baseline 
examination and not known to be deceased.   The 1987 and 1992 NHEFS was 
conducted on the entire non-deceased NHEFS cohort. 
 
In the USA, NHANES has a long history of successful and useful data collection 
activities with high response rates. The burden on the public is kept minimal, 
participation is voluntary, and there is no paperwork burden on businesses or 
health care providers. The technology innovations that are planned for NHANES 
will result in rapid and accurate data collection, data processing, and publication 
of results. 
 
The NHANES program has been very successful in recent years in setting the 
stage for national policy directions, consumer guidelines’ development, research 
priorities and contribution of material for research activities.  In 1997-1998, there 
were over 200 publications based on the NHANES and published in peer 
reviewed international journals.  This only represents those where NHANES was 
identified in the title or as a key word, those in English and those in the journals 
contained in certain computerised databases.  The subject of these publications 
reflects the full range of diseases and conditions across all ages of participants, 
preventive strategies, health promotion, and epidemiological and statistical 
methods.  
 
The number of people examined in a 12-month period is about the same as in 
previous NHANES, about 5,000.  NCHS first conduct a pilot test followed by two 
dress rehearsals prior to the main study. The purpose of the pilot test is to 
resolve timing and training issues and check the automated data collection 
systems and equipment. The dress rehearsals are used for further training of 
technicians and other staff for the main survey.  As in the previous NHANES 
people are screened using sample selection.   This is followed by detailed 
household interviews.  Sample persons are invited to receive physical 
examinations and health and dietary interviews in mobile examination centers 
(MEC's).  Home examinations consisting of a subset of exam components will be 
offered to those sample persons who are unwilling or unable to come to the MEC 
for the full examination. Various medical tests and procedures will be conducted 
to enable analysis of the relationship between health and nutrition status and 
disease risk factors, to measure the prevalence and comorbidity of diseases and 
disorders, to establish reference standards, and to monitor secular trends in 
health and nutrition status.  
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In NHANES III conducted from 1988 to 1994, blood specimens were collected 
from participants aged 12 years and older and stored frozen in liquid nitrogen or 
as cell cultures.  As a result of needing to collect more sample volume to 
accommodate out-of-range results that have to be repeated, large numbers of 
surplus serum samples have been stored frozen.  This means that both cell 
cultures and frozen white blood cells are available to researchers with funded 
research programs.   
 
Though participants in the survey signed an extensive consent form, specific 
mention of genetic testing was not included.  Given the scientific importance of 
this resource to the US, a proposal to develop a plan to make DNA available to 
the research community for de-identified testing was approved by the NHANES 
Board in 1996, and de-identified samples for DNA research are also available to 
funded researchers, after an extensive process of approval and scrutiny. 
 
NHANES is currently soliciting proposals for new content for 2001.  Proposals 
can address the addition of survey questions or laboratory analyses of blood, 
urine and potentially specimens from other sources.  Proposals for inclusion of 
examination components and other physical measures are not being considered, 





There has been a recent and significant increase in interest in population health 
surveys in Canada.  After the 1978 Canada Health Survey, there was a hiatus of 
almost a decade in large-scale household interview surveys.  The main recent 
surveys are the 1985 module in the (telephone) General Social Survey, 1986 
postcensal survey on disabilities and the 1987 and 1990 Ontario health surveys.  
There have also been a number of more focused surveys on topics such as 
smoking, health promotion and fitness. 
 
The Canadian Government approved permanent multimillion dollar funding for a 
biennial National Population Health Survey in 1992, which is longitudinal and 
includes a set of core population health status measures.  Most recently, Canada 
has progressed steadily towards a comprehensive plan for national population 
health information, which includes significant innovations in record linkage and a 
framework and philosophy to bind the various strategies into a coherent 
infrastructure incorporating a cost-effective approach and staged development. 
 
Planning is at a very early stage for a biomedical risk factor survey, and the 
Canadians are just starting to develop a process for its design.  A paper has been 
commissioned from the Institute for Clinical Evaluative Sciences in Toronto.  
This is a survey of major physical measures’ surveys, particularly those run at the 
national level.  There is considerable consultation being planned with key 
stakeholders, and Statistics Canada is keen to begin refining the list of physical 
measures and their rationales that will be the focus of the survey.  The first step 
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being taken is the compilation of the scientific and health information and policy 
rationales that underpin a survey of this kind and then questions of feasibility and 
operational considerations will be examined.  They are planning to spend from 
$5 to 10 million, and the final amount of funding will depend on the strength of 
the rationales/needs for different kinds of measures.  For example, if there is a 
constituency for measuring pulmonary function, this is a discrete and rather 
costly measure, but one that is much more feasible now with CAPI and portable 
spirometry.  They have not yet considered sample design issues. 
 
 
8.3 United Kingdom 
 
The Health Survey for England is a series of annual surveys about the health of 
people in England.  The survey provides regular information on various aspects 
of population health and monitors some national health goals and targets.   
 
The Health Survey was first proposed in 1990 to improve information of 
morbidity by the (then) newly created Central Health Monitoring Unit within the 
Department of Health. This information is used to underpin and improve 
targeting of nationwide health policies.  The survey was carried out in 1991-1993 
by the Office for Population Censuses and Surveys which is now part of the 
Office for National Statistics.  From 1994 onwards, the survey has been carried 
out by the Joint Survey Unit of the National Centre of Social Research and the 
Department of Epidemiology and Public Health at University College London.   
 
The Health Survey is designed to be nationally representative of people of 
different age, sex, geographic area and socio-demographic circumstances.  The 
1991 and 1992 surveys had a limited population sample of about 3,000 and 
4,000 adults respectively.  For 1993 to 1996, the adult sample was boosted to 
about 16,000 to enable analysis by socio-economic characteristics and health 
regions.  In 1995 for the first time, a sample of about 4,000 children was also 
introduced.  For the 1997 Health Survey, the sample was about 7,000 children 
and 9,000 adults. 
 
The aims of the Health Survey for England are: 
    to provide annual data about the nation's health;  
    to estimate the proportion of the population with specific health conditions;  
    to estimate the prevalence of risk factors associated with those conditions;  
    to assess the frequency with which combinations of risk factors occur;  
    to examine differences between population sub-groups;  
    to monitor targets in the health strategy; and 
    (from 1995) to measure the height of children at different ages, replacing the  
    national study of health and growth. 
 
The Health Survey combines questionnaire answers and physical measurements 
as well as other objective measures such as analysis of blood samples and lung 
function tests.  The Health Survey for England contains a 'core' which is repeated 
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each year and each survey year has one or more modules on subjects of special 
interest.  The 'core' includes: 
    questions on general health and psycho-social indicators  
    smoking  
    alcohol  
    demographic and socio-economic indicators  
    questions about use of health services and prescribed medicines - the focus 
for  
    these may vary from year to year to suit the modular content of the survey.  
    blood pressure  
    measurements of height, weight and blood pressure  
 
The modules may be about a single topic, several topics or about population 
groups. The modules to date have been: 
     1993 cardiovascular disease 
     1994 cardiovascular disease 
     1995 asthma 
            accidents 
            disability 
     1996 asthma 
                accidents 
                special measures of general health (Euroquol, SF36) 
     1997 children and young people 
     1998 cardiovascular disease 
1999 ethnic groups 
2000 older people, social exclusion 
2001 disability, asthma, accidents. 
 
From 1993 to 1994 when cardiovascular diseases were the main focus, the 
surveys included physical measures and the taking of a blood sample.  The 
response rate for the first stage interview was 71% and blood samples were 
obtained from 51% of the initial sample.  A range of blood analyses was 
performed and a small sample was stored for possible future analysis with 
participant consent. 
 
For 1998 where cardiovascular disease is the main focus, the following 
blood analyses were undertaken: 
    total cholesterol  
    HDL cholesterol  
    fibrinogen (a clotting agent - raised levels can contribute to cardiovascular  
    disease and stroke)  
    haemoglobin  
    ferritin  
    C-reactive protein. 
 
For the years in which asthma was included, blood samples were analysed for 
Immunoglobulin E (IgE - the antibody responsible for the immediate type of 
immune response - a raised level of IgE is found in people with an atopic 
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predisposition) and house dust mite specific IgE.  Cotinine (a metabolite of 
nicotine) levels have also been included in the survey to measure for smoking 
and are particularly useful in assessing passive smoking.  Cotinine levels can be 
obtained from either a blood sample or a saliva sample. 
 
 
8.4 New Zealand (NZ) 
 
Experience in New Zealand with biomedical risk factor surveying is reflected in 
the 1996/97 NZ Health Survey that was linked to the 1997 National Nutrition 
Survey.  The cost of the National Nutrition Survey (NNS) was $NZ 3.5 million 
over three years in contracts, excluding costs to the Ministry of Health for staff 
time, and the cost of the National Health Survey was $NZ 750,000.  The NNS 
was run by the University of Otago under contract. 
 
The linkage with the NZ Health Survey was the result of financial pressures 
preventing separate funding of the NNS.  It was the best way to ensure that both 
surveys occurred.  Those who were involved with the surveys do not recommend 
a linkage in the future.  It reduced the response rate in the second survey due to 
the multiple dropout opportunities (NNS was 50.1%).  There are some 
advantages though, now having a linked data set to dredge for further 
information.  It was believed it may save money, although no analyses were done 
to confirm this. 
 
Blood sampling was crucial to the NNS.  It has provided good data for blood 
cholesterol and iron deficiency.  It provides some validation for the nutrient 
information where available.  For example, dietary inadequacy of iron was very 
high from the 24-HDR data, yet blood samples showed iron deficiency anaemia 
was not an issue for nearly all of the female population.  Biological markers are 
the way of the future and are a natural adjunct to the dietary information.  A large 
number of different assays were investigated for inclusion in the NNS, however, 
due to financial and logistical constraints, only a limited number occurred.  Urine 
samples and bioimpedance were also considered, but eventually rejected. 
 
The results of the NNS have shown three key nutrition issues in NZ - obesity and 
overweight, food security and calcium inadequacy.  These are all now priorities 
within the Ministry for policy work, but given a number of constraints, and the 





Logistical issues for biomedical sampling  
 
 
1. Collection of blood and other samples 
• Occupational health and safety training of staff, if recruited for the survey 
• Equipment and location of venesection clinics, or in-home sampling? 
• Informed consent will be complex– especially if genetic or DNA testing 
• Sample identification using at least 2-3 indicators- e.g. name, date of 
birth, code, Medicare number 
• Documentation of participant demographics and GP, linkage of 
information to sample needs to be established, bar-code identification 
would be useful for database entry - (using light pens) 
• Appropriate tubes (preferably Vacutainer type) with anticoagulant, 
determine volume of blood required, blood mixing apparatus available, 
possible piggy backing of tests to a single tube but an original sample is 
required for viral studies and for archiving of samples 
• Appropriateness/usefulness of viral markers needs to be established e.g. 
Hepatitis A antibody disappears in some cases, accurate vaccination 
history (if available) will be relevant,  
• Biological false positive rate for each test to be considered 
• Sample stability for reliability of test result - sample-test turnaround time 
including transport time for rural and remote areas. 
 
2. Transport of blood samples 
• Validated temperature controlled storage and transport of specimens 
needed 
• Sample receipt and identification during transport 
• Must meet requirements of International Air Transport Authority standards 
and their equivalents for road and rail transport re regulations for 
unscreened blood samples, depend on the volume of samples (i.e. for 
samples above and below 50 mls. there are different costs and 
regulations). 
 
3. Testing of Blood samples 
• Need establishment of normal ranges 
• Define sensitivity and specificity of test, technique or kit standardisation 
• One laboratory only per test and/or per state to ensure laboratory 
standardisation? 
• Establish confirmatory test and decision protocol for reactive results. 
 
4. Verification of test results 
• Accreditation of laboratory: National Accreditation of Testing Authorities 
• Approved and acceptable results, in line with Royal College of Pathologists 
Quality Assurance Program or similar performance program. 
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5. Test interpretation 
• Clinical outcome management protocol, standard letters, information 
leaflets for participants and their doctors need to be developed 
• Pre-test counselling for viral or genetic testing required 
• Should an opportunity for public education of health risks be taken during 
interview? 
• Ethical approval and consideration of how to achieve fully informed 
consent should be addressed (particularly for DNA testing) 
• Problems of ownership of samples and data –(particularly relevant for 
stored sera – eg. gene patenting issues from the US arm of Human 
Genome Project) 
• Duty of care to notify outcomes needs to be addressed 
• Need to establish management protocols and follow-up for biological 
false positive or indeterminate results especially where participants might 
be concerned eg. viral markers.  Follow-up and repeat testing with later 
generation screening tests should be offered.  Liability due to stress from 
false notification needs to be assessed. 
• Tracing of participants will be an issue throughout the study, particularly if 
longitudinal - strategies using Medicare database, electoral role, death 
notification etc. should be considered. 
 
6. Notification of test results 
• Development of standard letters and protocols 
• Relevance of findings with health management information should be 
given to participant -? Liability if study outcome for some is poor health 
but those groups/ individuals not advised of risk minimisation behaviour. 
• Notification by mail or phone of positive viral markers is undesirable- 
should be briefed in person by a trained counsellor or GP with information 
tools.  Best handled through GP to ensure follow-up.  E.g. notification 
letters should not be sent to be received on a Friday when counselling is 
not available over a weekend.  Links with established services and 
resources for HIV, Hepatitis C etc should be made. 
• Issues of poor participant traceability can be even within one week of 
sample collection (Australian Red Cross Blood Service new donor and 
Lookback experience). 
 
7. Counselling and follow-up 
• Trained staff required for viral notification 
• Consider notification also under state public health legislation 
• Confidentiality especially of positive viral markers. 
 
8. Sample Archiving and repository establishment 
• ? Archiving of samples - plasma, DNA - cost, site - monitoring of alarmed 
freezers at appropriate temperature, stability of sample storage prior to 
archiving should be established 
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• Where to site archive (one or many)? Ongoing maintenance costs for 
storage, define ownership, decision making process and approval for any 
further testing 
• Consider liability issues of non - de-linked samples and performance of 
new screening tests without consent  
• Value of national plasma sample archive for future screening of new 
viruses- de-linking will remove liability of notification (if participant 
informed) but less use as a longitudinal study. 
• Should specimens be linked or de-linked? - Ongoing liability and 
responsibility to inform of later test results from archiving - follow-up 
issues, ethics to resolve uncertain test results with evolution of newer, 
better tests. 
 
